222 related articles for article (PubMed ID: 6420600)
41. Keratinocyte-derived T cell costimulation induces preferential production of IL-2 and IL-4 but not IFN-gamma.
Goodman RE; Nestle F; Naidu YM; Green JM; Thompson CB; Nickoloff BJ; Turka LA
J Immunol; 1994 Jun; 152(11):5189-98. PubMed ID: 7910619
[TBL] [Abstract][Full Text] [Related]
42. Properties of reticulum cell sarcomas in SJL/J mice. V. Nature of reticulum cell sarcoma surface antigen which induces proliferation of normal SJL/J T cells.
Ponzio NM; David CS; Shreffler DC; Thorbecke GJ
J Exp Med; 1977 Jul; 146(1):132-145. PubMed ID: 68988
[TBL] [Abstract][Full Text] [Related]
43. Murine lymph node antigen presenting cells are the main source of interleukin-6 in the initiation of delayed-type hypersensitivity.
Ulrich P; Vohr HW
Eur Cytokine Netw; 1996 Sep; 7(3):401-7. PubMed ID: 8954184
[TBL] [Abstract][Full Text] [Related]
44. Assessment of preferential T-helper 1 or T-helper 2 induction by low molecular weight compounds using the local lymph node assay in conjunction with RT-PCR and ELISA for interferon-gamma and interleukin-4.
Vandebriel RJ; De Jong WH; Spiekstra SW; Van Dijk M; Fluitman A; Garssen J; Van Loveren H
Toxicol Appl Pharmacol; 2000 Jan; 162(2):77-85. PubMed ID: 10637130
[TBL] [Abstract][Full Text] [Related]
45. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens.
Hunter CA; Chizzonite R; Remington JS
J Immunol; 1995 Nov; 155(9):4347-54. PubMed ID: 7594594
[TBL] [Abstract][Full Text] [Related]
46. Induction of global anergy rather than inhibitory Th2 lymphokines mediates posttrauma T cell immunodepression.
De AK; Kodys KM; Pellegrini J; Yeh B; Furse RK; Bankey P; Miller-Graziano CL
Clin Immunol; 2000 Jul; 96(1):52-66. PubMed ID: 10873428
[TBL] [Abstract][Full Text] [Related]
47. [Interaction of lymphoma cells and normal lymphoid cells in SJL/J mice leading to lymphokine production].
Hayama T; Sawada S
Rinsho Ketsueki; 1984 Apr; 25(4):471-8. PubMed ID: 6332211
[No Abstract] [Full Text] [Related]
48. Defects in the regulation of anti-DNA antibody production in aged lupus-prone (NZB x NZW)F1 mice: analysis of T-cell lymphokine synthesis.
Sato MN; Minoprio P; Avrameas S; Ternynck T
Immunology; 1995 May; 85(1):26-32. PubMed ID: 7635519
[TBL] [Abstract][Full Text] [Related]
49. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
Kelso A; MacDonald HR; Smith KA; Cerottini JC; Brunner KT
J Immunol; 1984 Jun; 132(6):2932-8. PubMed ID: 6233365
[TBL] [Abstract][Full Text] [Related]
50. Ia-dependent interleukin 2 production in syngeneic cellular interactions.
Lattime EC; Gillis S; Pecoraro G; Stutman O
J Immunol; 1982 Jan; 128(1):480-5. PubMed ID: 6459377
[TBL] [Abstract][Full Text] [Related]
51. IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells.
Bianchi R; Grohmann U; Belladonna ML; Silla S; Fallarino F; Ayroldi E; Fioretti MC; Puccetti P
J Immunol; 1996 Aug; 157(4):1589-97. PubMed ID: 8759743
[TBL] [Abstract][Full Text] [Related]
52. T-cell lymphokine response to orally administered proteins during priming and unresponsiveness.
Hoyne GF; Callow MG; Kuhlman J; Thomas WR
Immunology; 1993 Apr; 78(4):534-40. PubMed ID: 8495970
[TBL] [Abstract][Full Text] [Related]
53. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL 2 deficiency in C3H-lpr/lpr mice.
Davidson WF; Roths JB; Holmes KL; Rudikoff E; Morse HC
J Immunol; 1984 Aug; 133(2):1048-56. PubMed ID: 6610701
[TBL] [Abstract][Full Text] [Related]
54. T-cell responses to orally administered antigens. Study of the kinetics of lymphokine production after single and multiple feeding.
Hoyne GF; Thomas WR
Immunology; 1995 Feb; 84(2):304-9. PubMed ID: 7751007
[TBL] [Abstract][Full Text] [Related]
55. Interferon-gamma and growth factor production by murine T cells derived from three different lymphoid tissues.
Höidén I; Möller G
Eur J Immunol; 1991 Nov; 21(11):2703-9. PubMed ID: 1936119
[TBL] [Abstract][Full Text] [Related]
56. Regulation of reticulum cell sarcoma tumor growth in SJL/J mice by a serum inhibitor affecting T-cell proliferation.
Sakano T; Wilbur SM; Bonavida B
Cancer Res; 1985 Apr; 45(4):1573-8. PubMed ID: 3884142
[TBL] [Abstract][Full Text] [Related]
57. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
[TBL] [Abstract][Full Text] [Related]
58. Concanavalin A-induced human lymphocyte mitogenic factor: activity distinct from interleukin 1 and 2.
Duncan MR; George FW; Hadden JW
J Immunol; 1982 Jul; 129(1):56-62. PubMed ID: 6806367
[TBL] [Abstract][Full Text] [Related]
59. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production.
Macatonia SE; Doherty TM; Knight SC; O'Garra A
J Immunol; 1993 May; 150(9):3755-65. PubMed ID: 8097224
[TBL] [Abstract][Full Text] [Related]
60. Inappropriate alloantigen-like specificities detected on reticulum cell sarcomas of SJL/J mice: characterization and biologic role.
Bonavida B; Roman JM; Hutchinson IV
Transplant Proc; 1980 Mar; 12(1):59-64. PubMed ID: 6154360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
